Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

61 results
Display

Hyperkalemia from preoperative non-steroidal anti-inflammatory drugs and angiotensin II receptor blockers in patients with nephropathy

Song HK, Jang Y, Nam JW, You JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intra-operative refractory hypotension in patient chronically treated with renin-angiotensin system antagonists: A case report

Kim ES, Kwon OK, No HC, Kim JE

Chronic treatment with renin-angiotensin system antagonists frequently causes deleterious hypotension during anesthesia. We present a case of marked intra-operative refractory hypotension in a 61-year-old male patient undergoing elective total thyroidectomy....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Angiotensin II on ZO-1 in Glomerular Epithelial Cells

Koo HH, Ha TS

  • KMID: 2307207
  • Korean J Nephrol.
  • 2007 Sep;26(5):516-525.
PURPOSE: Angiotensin II plays a potent role in renal injury not only by vasoconstrictive effects but also by biochemical effects. We investigated the effect of angiotensin II on ZO-1 (zonular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New drugs for treatment of hypertension

Park CG

  • KMID: 1927357
  • Korean J Med.
  • 2004 Nov;67(5):461-466.
Recently several kinds of new antihypertensive agents were introduced. Diuretics such as indapamide, metyrazone and eprelerone have less side effects compared to thiazide, and have an effect in renal insufficiency....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Angiotensin II Receptor Blockers in Proteinuric IgA Nephropathy

Noh JH, Hwang YC, Lee TW, Ihm CG

  • KMID: 2079164
  • Korean J Nephrol.
  • 2001 Mar;20(2):277-282.
Whether immunosuppressive therapy may have beneficial effects in the treatment of IgA nephropathy remains controversial. ACE inhibitor or angiotensin II receptor antagonist(AIIA) are suggested to reduce urinary protein excretion(Up) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Closer Look at Hyperkalemia

Chung S, Park CW

  • KMID: 2305754
  • Korean J Med.
  • 2011 Jan;80(1):20-30.
Therapeutic manipulation of the renin-angiotensin-aldosterone system (RAAS) is an important strategy for improving hypertension, diabetes, cardiovascular disease, and chronic kidney disease. Development of hyperkalemia after the administration of RAAS inhibitors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypokalemic Hypertension Leading to a Diagnosis of Autosomal Dominant Polycystic Kidney Disease

Vutthikraivit W, Assanatham M, Sriphrapradang C

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disease. Hypertension is common and occurs before decline in renal function. However, the coexistence of hypertension and hypokalemia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypocalvaria of Newborn Infant: Intrauterine Exposure to an Angiotensin Receptor Blocker

Ri S, Shin J, Je BK, Choi BM

Angiotensin receptor blockers are contraindicated drugs during pregnancy because of their potential fetotoxicity, including oligohydramnios, anuria, renal tubular dysplasia, limb contractures, cranial ossification defects, prolonged patent ductus arteriosus, and even...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Issues on the Angiotensin II Receptor Blocker in Cardiovascular Disease

Yoon HJ, Kim KH

To reduce cardio-cerebro-vascular and renal morbidity and mortality, the current guidelines on the treatment of hypertension recommend evaluating and managing total cardiovascular risks of the patient with hypertension, not just...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nursing Management in Diabetes during Pregnancy

Park JE

The ongoing epidemics of obesity and diabetes have led to higher incidence of gestational diabetes mellitus and pregestational diabetes. GDM is diabetes diagnosed in the second or third trimester of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oral pharmacological treatment of congestive heart failure

Yoo BS

Congestive heart failure (CHF) is a growing epidemiologic and clinical problem, and is increasing in incidence, prevalence and mortality. Therefore, the optimal treatment of heart failure (HF) is important to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis

Yu BC, Lee MS, Moon JJ, Choi SJ, Kim JK, Hwang SD, Park MY

BACKGROUND: Previous studies have shown that aldosterone antagonists have a proteinuria-lowering effect in patients with proteinuria and progressive proteinuric disease not adequately controlled by the use of angiotensin receptor blockers...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of brain angiotensin II receptor antagonists and antisense oligonucleotide on drinking and renal renin in rats

Cho HK, Yang EK, Han HS, Lee WJ, Phillips M

  • KMID: 1982600
  • Korean J Physiol Pharmacol.
  • 2000 Apr;4(2):137-142.
The physiological roles of brain angiotensin II in mediating water deprivation-induced drinking and in regulating renal renin release were assessed in male Sprague-Dawley rats. Specific AT1 receptor antagonists, losartan and SK 1080, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Term Delivery with Diagnosis of Severe Oligohydramnios after Exposure to Glimepiride, Metformin and Antihypertensive agents Including Angiotensin Receptor Antagonist up to Approximately 20 Weeks of Pregnancy

Kwak DW, Yoo IS, Choi JS

Various fetal and maternal conditions are known to be associated with oligohydramnios. In general, oligohydramnios developed early in pregnancy is less common but frequently has a poor prognosis. The use...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Neonate with Acute Renal Failure after Maternal Treatment with Angiotensin II Receptor Blocker

Ra JJ, Eun HS, Lee SM, Park MS, Namgung R, Lee C, Park KI

  • KMID: 2280895
  • Korean J Perinatol.
  • 2012 Dec;23(4):286-291.
Hypertension is common medical problem encountered during pregnancy. However medication administered for maternal hypertension may cause fetal or neonatal complications. Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Angiotensin II Receptor Blockers in the Treatment of Congestive Heart Failure

Jeon ES

Pharmacotherapy for the treatment of heart failure has advanced considerably in recent years, and clinical trials have demonstrated the favorable long-term effects of angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypertensive response to exercise: mechanisms and clinical implication

Kim D, Ha JW

A hypertensive response to exercise (HRE) is frequently observed in individuals without hypertension or other cardiovascular disease. However, mechanisms and clinical implication of HRE is not fully elucidated. Endothelial dysfunction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hyperkalemia in Chronic Kidney Disease

Han SW

  • KMID: 2052258
  • Electrolyte Blood Press.
  • 2005 Nov;3(2):71-78.
Potassium balance and serum potassium level are maintained until very late in chronic kidney disease (CKD), mainly because of an increase in renal and colonic excretion. Hyperkalemia may develop earlier...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Kidney Transplant Patient with a Facial Redness

Jung JH, Jang JW, Lim JH, Lee JY, Lee S, Yu HC, Hwang HP, Park SK

Posttransplant erythrocytosis (PTE) is a common complication of renal transplantation, which can occur in approximately 10% to 15% of renal transplant patients and usually affects males with relatively good renal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An update on new drugs for diabetic nephropathy

Park CW

  • KMID: 2305776
  • Korean J Med.
  • 2009 Dec;77(6):686-694.
Prevention, early detection, and treatment of renal disease in diabetic patients are becoming major healthcare issues. It is well known that hyperglycemia is a major risk factor for the development...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr